Potential Therapeutic Targets for Combination Antibody Therapy against <i>Pseudomonas aeruginosa</i> Infections
Despite advances in antimicrobial therapy and even the advent of some effective vaccines, <i>Pseudomonas aeruginosa (P. aeruginosa)</i> remains a significant cause of infectious disease, primarily due to antibiotic resistance. Although <i>P. aeruginosa</i> is commonly treatab...
Saved in:
Main Authors: | Luke L. Proctor (Author), Whitney L. Ward (Author), Conner S. Roggy (Author), Alexandra G. Koontz (Author), Katie M. Clark (Author), Alyssa P. Quinn (Author), Meredith Schroeder (Author), Amanda E. Brooks (Author), James M. Small (Author), Francina D. Towne (Author), Benjamin D. Brooks (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential Therapeutic Targets for Combination Antibody Therapy Against <i>Staphylococcus aureus</i> Infections
by: Sharon Ke, et al.
Published: (2024) -
<i>Pseudomonas aeruginosa</i> Biofilm Formation, Infections and Treatments
Published: (2021) -
Antimicrobial Treatment of <i>Pseudomonas aeruginosa</i> Severe Sepsis
by: Johnny Zakhour, et al.
Published: (2022) -
Treatment Heterogeneity in <i>Pseudomonas aeruginosa</i> Pneumonia
by: Aisling R. Caffrey, et al.
Published: (2022) -
The Basis for Natural Multiresistance to Phage in <i>Pseudomonas aeruginosa</i>
by: Christine Pourcel, et al.
Published: (2020)